Search
for
Sort by
Research 481–510 of 1000+
- A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
- Lepidoptera Lexicon: Metaphorical Descriptors in Dermatology
- Extensive Spiculated Follicular Porokeratosis With Alopecia: A Case Report
- 43853 Case of Reactive Keratoacanthomas arising Eight Years After Multicolored Tattoo Placement
- Pancreatic cancer
- ESCITALOPRAM
- Treatment of alopecia areata with squaric acid dibutylester
- Female pattern hair loss
- Common causes of paediatric alopecia
- Case Report: Successful Use of Minoxidil to Promote Facial Hair Growth in an Adolescent Transgender Male
- Clinical and histological recovery of non-thymoma-associated exfoliative dermatitis in a cat treated with ciclosporin A
- Novel Technologies for Exploring the Skin–Brain Axis
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Scabies with Secondary Infection Resembling Kerion-Type Tinea Capitis
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Culprits of Medication-Induced Telogen Effluvium, Part 1
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Mutations in ABCB6 Cause Dyschromatosis Universalis Hereditaria
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- Physiologic changes of pregnancy: A review of the literature
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Under Development JAK Inhibitors for Dermatologic Diseases
- Discoid lupus erythematosus successfully treated with deucravacitinib
- Skin manifestations associated with systemic diseases – Part I
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis